ARCHIVES

Phase III Vaccine Trial Fails To Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

Funding Opportunities: NCI Seeks SBIR Applicants For Research On Detection Assays

July 3, 1998

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

ASCO honors physicians for clinical trials participation.

June 4, 2004

Centers Recruting Patients With Mantle Cell Lymphoma

October 29, 2004